Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IRF9
|
ENSG00000213928.4 | interferon regulatory factor 9 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF9 | hg19_v2_chr14_+_24630465_24630531 | 0.95 | 1.3e-13 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_+_42798094 | 43.21 |
ENST00000398598.3
ENST00000455164.2 ENST00000424365.1 |
MX1
|
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
chr4_-_76944621 | 34.46 |
ENST00000306602.1
|
CXCL10
|
chemokine (C-X-C motif) ligand 10 |
chr12_+_113344755 | 30.98 |
ENST00000550883.1
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr1_+_79086088 | 30.44 |
ENST00000370751.5
ENST00000342282.3 |
IFI44L
|
interferon-induced protein 44-like |
chr2_-_7005785 | 28.44 |
ENST00000256722.5
ENST00000404168.1 ENST00000458098.1 |
CMPK2
|
cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
chr17_+_6659153 | 27.97 |
ENST00000441631.1
ENST00000438512.1 ENST00000346752.4 ENST00000361842.3 |
XAF1
|
XIAP associated factor 1 |
chr13_-_43566301 | 20.84 |
ENST00000398762.3
ENST00000313640.7 ENST00000313624.7 |
EPSTI1
|
epithelial stromal interaction 1 (breast) |
chr12_+_113344582 | 20.33 |
ENST00000202917.5
ENST00000445409.2 ENST00000452357.2 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr12_+_113344811 | 17.97 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_-_122283424 | 17.35 |
ENST00000477522.2
ENST00000360356.2 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr3_-_122283079 | 17.12 |
ENST00000471785.1
ENST00000466126.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr1_-_150738261 | 16.41 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr1_+_79115503 | 15.31 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr12_+_113376157 | 15.23 |
ENST00000228928.7
|
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr10_+_91092241 | 15.13 |
ENST00000371811.4
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr21_+_42733870 | 14.26 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr6_-_82462425 | 13.19 |
ENST00000369754.3
ENST00000320172.6 ENST00000369756.3 |
FAM46A
|
family with sequence similarity 46, member A |
chr14_+_24630465 | 13.12 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr3_+_122283064 | 13.06 |
ENST00000296161.4
|
DTX3L
|
deltex 3-like (Drosophila) |
chr9_+_5510492 | 12.91 |
ENST00000397745.2
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr9_+_5510558 | 12.60 |
ENST00000397747.3
|
PDCD1LG2
|
programmed cell death 1 ligand 2 |
chr9_-_32526184 | 11.78 |
ENST00000545044.1
ENST00000379868.1 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr3_+_122399444 | 11.25 |
ENST00000474629.2
|
PARP14
|
poly (ADP-ribose) polymerase family, member 14 |
chr17_-_40264692 | 10.94 |
ENST00000591220.1
ENST00000251642.3 |
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr3_-_122283100 | 10.09 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
chr22_+_18632666 | 9.88 |
ENST00000215794.7
|
USP18
|
ubiquitin specific peptidase 18 |
chr6_-_32806506 | 9.05 |
ENST00000374897.2
ENST00000452392.2 |
TAP2
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) Uncharacterized protein |
chr10_+_91174314 | 8.99 |
ENST00000371795.4
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5 |
chr11_-_615570 | 8.90 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr11_-_57335280 | 8.12 |
ENST00000287156.4
|
UBE2L6
|
ubiquitin-conjugating enzyme E2L 6 |
chr11_-_4414880 | 8.12 |
ENST00000254436.7
ENST00000543625.1 |
TRIM21
|
tripartite motif containing 21 |
chr19_+_10196981 | 8.00 |
ENST00000591813.1
|
C19orf66
|
chromosome 19 open reading frame 66 |
chr2_+_7017796 | 7.68 |
ENST00000382040.3
|
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr15_+_74287009 | 7.47 |
ENST00000395135.3
|
PML
|
promyelocytic leukemia |
chr13_+_50070491 | 7.25 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr15_+_74287035 | 7.14 |
ENST00000395132.2
ENST00000268059.6 ENST00000354026.6 ENST00000268058.3 ENST00000565898.1 ENST00000569477.1 ENST00000569965.1 ENST00000567543.1 ENST00000436891.3 ENST00000435786.2 ENST00000564428.1 ENST00000359928.4 |
PML
|
promyelocytic leukemia |
chr13_+_50070077 | 7.03 |
ENST00000378319.3
ENST00000426879.1 |
PHF11
|
PHD finger protein 11 |
chr11_-_615942 | 6.92 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr3_-_142166796 | 6.59 |
ENST00000392981.2
|
XRN1
|
5'-3' exoribonuclease 1 |
chr4_-_169239921 | 6.50 |
ENST00000514995.1
ENST00000393743.3 |
DDX60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr1_+_948803 | 6.16 |
ENST00000379389.4
|
ISG15
|
ISG15 ubiquitin-like modifier |
chr2_-_106810783 | 5.83 |
ENST00000283148.7
|
UXS1
|
UDP-glucuronate decarboxylase 1 |
chr2_-_152146385 | 5.80 |
ENST00000414946.1
ENST00000243346.5 |
NMI
|
N-myc (and STAT) interactor |
chr12_+_113376249 | 5.80 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chr12_-_121477039 | 5.64 |
ENST00000257570.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr15_+_74287118 | 5.62 |
ENST00000563500.1
|
PML
|
promyelocytic leukemia |
chr2_-_106810742 | 5.58 |
ENST00000409501.3
ENST00000428048.2 ENST00000441952.1 ENST00000457835.1 ENST00000540130.1 |
UXS1
|
UDP-glucuronate decarboxylase 1 |
chr5_-_95297678 | 5.48 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr2_-_220252603 | 5.42 |
ENST00000322176.7
ENST00000273075.4 |
DNPEP
|
aspartyl aminopeptidase |
chr7_+_100728720 | 5.29 |
ENST00000306085.6
ENST00000412507.1 |
TRIM56
|
tripartite motif containing 56 |
chr5_-_95297534 | 5.26 |
ENST00000513343.1
ENST00000431061.2 |
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr6_-_31324943 | 5.03 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr14_+_94577074 | 4.69 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
chr2_-_163175133 | 4.10 |
ENST00000421365.2
ENST00000263642.2 |
IFIH1
|
interferon induced with helicase C domain 1 |
chr4_-_169401628 | 3.94 |
ENST00000514748.1
ENST00000512371.1 ENST00000260184.7 ENST00000505890.1 ENST00000511577.1 |
DDX60L
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like |
chr3_-_142166904 | 3.93 |
ENST00000264951.4
|
XRN1
|
5'-3' exoribonuclease 1 |
chr9_+_74764278 | 3.74 |
ENST00000238018.4
ENST00000376989.3 |
GDA
|
guanine deaminase |
chr16_-_74734672 | 3.63 |
ENST00000306247.7
ENST00000575686.1 |
MLKL
|
mixed lineage kinase domain-like |
chr4_+_186990298 | 3.59 |
ENST00000296795.3
ENST00000513189.1 |
TLR3
|
toll-like receptor 3 |
chr5_-_59481406 | 3.57 |
ENST00000546160.1
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr10_+_115439282 | 3.54 |
ENST00000369321.2
ENST00000345633.4 |
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr17_+_41363854 | 3.52 |
ENST00000588693.1
ENST00000588659.1 ENST00000541594.1 ENST00000536052.1 ENST00000331615.3 |
TMEM106A
|
transmembrane protein 106A |
chr10_+_115439699 | 3.40 |
ENST00000369315.1
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr17_+_78234625 | 3.38 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
chr10_+_115439630 | 3.24 |
ENST00000369318.3
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase |
chr1_-_154580616 | 2.98 |
ENST00000368474.4
|
ADAR
|
adenosine deaminase, RNA-specific |
chr12_-_121476959 | 2.96 |
ENST00000339275.5
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr6_+_126240442 | 2.91 |
ENST00000448104.1
ENST00000438495.1 ENST00000444128.1 |
NCOA7
|
nuclear receptor coactivator 7 |
chr9_+_102668915 | 2.90 |
ENST00000259400.6
ENST00000531035.1 ENST00000525640.1 ENST00000534052.1 ENST00000526607.1 |
STX17
|
syntaxin 17 |
chr6_-_33282163 | 2.78 |
ENST00000434618.2
ENST00000456592.2 |
TAPBP
|
TAP binding protein (tapasin) |
chr11_-_86383157 | 2.56 |
ENST00000393324.3
|
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr2_-_55920952 | 2.51 |
ENST00000447944.2
|
PNPT1
|
polyribonucleotide nucleotidyltransferase 1 |
chr18_-_25616519 | 2.50 |
ENST00000399380.3
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal) |
chr12_+_6881678 | 2.48 |
ENST00000441671.2
ENST00000203629.2 |
LAG3
|
lymphocyte-activation gene 3 |
chr3_+_187086120 | 2.45 |
ENST00000259030.2
|
RTP4
|
receptor (chemosensory) transporter protein 4 |
chr17_-_4167142 | 2.41 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chr11_-_86383650 | 2.37 |
ENST00000526944.1
ENST00000530335.1 ENST00000543262.1 ENST00000524826.1 |
ME3
|
malic enzyme 3, NADP(+)-dependent, mitochondrial |
chr3_-_121379739 | 2.36 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr12_-_121476750 | 2.29 |
ENST00000543677.1
|
OASL
|
2'-5'-oligoadenylate synthetase-like |
chr7_+_134551583 | 2.24 |
ENST00000435928.1
|
CALD1
|
caldesmon 1 |
chr4_+_37892682 | 2.20 |
ENST00000508802.1
ENST00000261439.4 ENST00000402522.1 |
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
chr3_-_142166846 | 2.01 |
ENST00000463916.1
ENST00000544157.1 |
XRN1
|
5'-3' exoribonuclease 1 |
chr6_+_37400974 | 1.67 |
ENST00000455891.1
ENST00000373451.4 |
CMTR1
|
cap methyltransferase 1 |
chr10_+_91061712 | 1.64 |
ENST00000371826.3
|
IFIT2
|
interferon-induced protein with tetratricopeptide repeats 2 |
chr5_-_142783175 | 1.59 |
ENST00000231509.3
ENST00000394464.2 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr3_-_146262352 | 1.49 |
ENST00000462666.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr4_+_89378261 | 1.21 |
ENST00000264350.3
|
HERC5
|
HECT and RLD domain containing E3 ubiquitin protein ligase 5 |
chr3_-_146262365 | 1.19 |
ENST00000448787.2
|
PLSCR1
|
phospholipid scramblase 1 |
chr18_-_67624160 | 1.14 |
ENST00000581982.1
ENST00000280200.4 |
CD226
|
CD226 molecule |
chr20_+_61436146 | 1.09 |
ENST00000290291.6
|
OGFR
|
opioid growth factor receptor |
chr3_-_46037299 | 1.07 |
ENST00000296137.2
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
chr3_-_146262488 | 1.06 |
ENST00000487389.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr9_-_32526299 | 1.02 |
ENST00000379882.1
ENST00000379883.2 |
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr6_+_106546808 | 1.01 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr5_-_142783694 | 0.98 |
ENST00000394466.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr3_-_146262428 | 0.97 |
ENST00000486631.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr19_-_12807395 | 0.97 |
ENST00000587955.1
|
FBXW9
|
F-box and WD repeat domain containing 9 |
chr2_-_37384175 | 0.95 |
ENST00000411537.2
ENST00000233057.4 ENST00000395127.2 ENST00000390013.3 |
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2 |
chr9_-_21995300 | 0.93 |
ENST00000498628.2
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A |
chr16_+_28962128 | 0.90 |
ENST00000564978.1
ENST00000320805.4 |
NFATC2IP
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 interacting protein |
chr5_-_137911049 | 0.89 |
ENST00000297185.3
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin) |
chr19_-_17516449 | 0.88 |
ENST00000252593.6
|
BST2
|
bone marrow stromal cell antigen 2 |
chr17_+_38296576 | 0.87 |
ENST00000264645.7
|
CASC3
|
cancer susceptibility candidate 3 |
chr6_-_33282024 | 0.73 |
ENST00000475304.1
ENST00000489157.1 |
TAPBP
|
TAP binding protein (tapasin) |
chr17_-_54991395 | 0.73 |
ENST00000316881.4
|
TRIM25
|
tripartite motif containing 25 |
chr9_+_74764340 | 0.58 |
ENST00000376986.1
ENST00000358399.3 |
GDA
|
guanine deaminase |
chr3_-_146262637 | 0.46 |
ENST00000472349.1
ENST00000342435.4 |
PLSCR1
|
phospholipid scramblase 1 |
chr14_-_57277163 | 0.42 |
ENST00000555006.1
|
OTX2
|
orthodenticle homeobox 2 |
chr14_-_57277178 | 0.37 |
ENST00000339475.5
ENST00000554559.1 ENST00000555804.1 |
OTX2
|
orthodenticle homeobox 2 |
chr14_-_67981916 | 0.26 |
ENST00000357461.2
|
TMEM229B
|
transmembrane protein 229B |
chr3_-_146262293 | 0.23 |
ENST00000448205.1
|
PLSCR1
|
phospholipid scramblase 1 |
chr19_-_12807422 | 0.22 |
ENST00000380339.3
ENST00000544494.1 ENST00000393261.3 |
FBXW9
|
F-box and WD repeat domain containing 9 |
chr9_+_33265011 | 0.18 |
ENST00000419016.2
|
CHMP5
|
charged multivesicular body protein 5 |
chrX_-_48858630 | 0.11 |
ENST00000376425.3
ENST00000376444.3 |
GRIPAP1
|
GRIP1 associated protein 1 |
chr2_+_205410723 | 0.06 |
ENST00000358768.2
ENST00000351153.1 ENST00000349953.3 |
PARD3B
|
par-3 family cell polarity regulator beta |
chrX_-_48858667 | 0.04 |
ENST00000376423.4
ENST00000376441.1 |
GRIPAP1
|
GRIP1 associated protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.5 | 28.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
5.2 | 57.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
5.1 | 20.5 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
4.5 | 44.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
4.4 | 17.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
3.4 | 34.5 | GO:1901509 | positive regulation of cAMP-mediated signaling(GO:0043950) regulation of endothelial tube morphogenesis(GO:1901509) |
3.2 | 15.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
2.5 | 20.2 | GO:0030578 | PML body organization(GO:0030578) |
2.5 | 12.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.2 | 6.7 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
2.1 | 21.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
2.0 | 8.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
1.5 | 15.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.5 | 7.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.5 | 10.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
1.4 | 25.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.4 | 159.7 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
1.2 | 5.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.9 | 2.6 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.9 | 4.3 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.8 | 2.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.8 | 2.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.8 | 5.3 | GO:0034340 | response to type I interferon(GO:0034340) |
0.7 | 3.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 16.2 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 5.4 | GO:2000373 | phosphatidylserine biosynthetic process(GO:0006659) regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.6 | 2.9 | GO:0016240 | autophagosome docking(GO:0016240) |
0.5 | 4.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.4 | 2.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.4 | 3.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.4 | 1.1 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.4 | 11.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 12.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.3 | 2.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 2.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 1.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 1.0 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.2 | 2.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 2.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 1.0 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 10.7 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.9 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.8 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.9 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 3.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 13.2 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 24.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 10.9 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.0 | 2.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 20.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
2.3 | 16.4 | GO:0036021 | endolysosome lumen(GO:0036021) |
1.3 | 9.3 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 3.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 9.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 2.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 2.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 2.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 14.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 10.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 3.6 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.1 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 5.0 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 63.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 20.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 11.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 34.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 7.7 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 12.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 178.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 5.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 6.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 65.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 3.9 | GO:0045121 | membrane raft(GO:0045121) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 101.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
7.1 | 28.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
6.9 | 34.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.1 | 56.0 | GO:0070403 | NAD+ binding(GO:0070403) |
1.9 | 9.3 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
1.8 | 12.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
1.2 | 9.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 22.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.8 | 4.9 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.6 | 2.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 7.1 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 2.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 16.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 11.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 2.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 9.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 37.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.3 | 10.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 5.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 5.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 3.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 2.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 4.7 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 57.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 5.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 7.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 15.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 9.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 2.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 2.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 13.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 7.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 23.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 38.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 1.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 3.9 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 2.4 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 11.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.4 | 34.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 19.9 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 10.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 14.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 18.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 10.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 3.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 16.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.8 | 259.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.1 | 15.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.9 | 25.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.6 | 12.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 34.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 20.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 3.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.3 | 4.3 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 10.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 20.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 6.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 21.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |